Toho Holdings Co., Ltd.

Tokyo Stock Exchange 8129.T

Toho Holdings Co., Ltd. Gross Profit for the year ending March 31, 2024: USD 787.21 M

Toho Holdings Co., Ltd. Gross Profit is USD 787.21 M for the year ending March 31, 2024, a -5.62% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Toho Holdings Co., Ltd. Gross Profit for the year ending March 31, 2023 was USD 834.10 M, a -6.58% change year over year.
  • Toho Holdings Co., Ltd. Gross Profit for the year ending March 31, 2022 was USD 892.86 M, a -0.50% change year over year.
  • Toho Holdings Co., Ltd. Gross Profit for the year ending March 31, 2021 was USD 897.34 M, a -16.39% change year over year.
  • Toho Holdings Co., Ltd. Gross Profit for the year ending March 31, 2020 was USD 1.07 B, a 6.21% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
Tokyo Stock Exchange: 8129.T

Toho Holdings Co., Ltd.

CEO Mr. Hiromi Edahiro
IPO Date Dec. 11, 2002
Location Japan
Headquarters 5-2-1, Daizawa
Employees 7,572
Sector Health Care
Industries
Description

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

Similar companies

7459.T

MediPal Holdings Corporation

USD 14.64

-0.31%

4553.T

Towa Pharmaceutical Co., Ltd.

USD 20.75

-0.79%

2784.T

Alfresa Holdings Corporation

USD 13.29

-0.18%

4540.T

Tsumura & Co.

USD 28.95

-1.90%

9987.T

Suzuken Co., Ltd.

USD 29.09

-1.76%

StockViz Staff

January 16, 2025

Any question? Send us an email